Botanical species · safety record

Coriaria myrtifolia

The EFSA Compendium of Botanicals holds 3 constituent measurements and 10 adverse-effect records for Coriaria myrtifolia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Coriaria myrtifolia L.

3Constituent measurements

10Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Tannins	Leaves	Solvent extraction	≤ 30 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Tannins	Leaves	Solvent extraction	≥ 15.6 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Coriamyrtin	Live plants	—	—	—	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Fruit unspecified	—	Human (as organism)	Case report	Resolve DOI
Neurotoxicity	Neurologic	Fruit unspecified	—	Human (as organism)	Case report	Resolve DOI
Pulmonary and cardiac	Respiratory	Fruit unspecified	—	Human (as organism)	Case report	Resolve DOI
Systemic	Neurologic	Fruit unspecified	—	Human (as organism)	Case report	Resolve DOI
Digestive	Digestive	Live plants	—	Human (as organism)	Acute toxicity	No resolvable identifier
Neurotoxicity	Neurologic: central nervous system	Fruit peel	Solvent extraction	Human (as organism)	Case report	No resolvable identifier
Neurotoxicity	Neurologic: central nervous system	Live plants	—	Human (as organism)	Acute toxicity	No resolvable identifier
Neurotoxicity	Neurologic: central nervous system	Live plants	—	Rabbit (as animal)	Acute toxicity	No resolvable identifier
Pulmonary and cardiac	Heart	Live plants	—	Human (as organism)	Acute toxicity	No resolvable identifier
Pulmonary and cardiac	Respiratory	Live plants	—	Human (as organism)	Acute toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

de Haro, L., Pommier, P., Tichadou, L., Hayek-Lanthois, M., Arditti, J. Poisoning by Coriaria myrtifolia Linnaeus: a new case report and review of the literature . Toxicon, 2005, vol. 46, no. 6, p. 600-603. DOI
Alonso Castell, P., Moreno Galdo, A., Sospedra Martinez, E., Roqueta Mas, J., Hidalgo Albert, E., Iglesias Berengue, J. Serious intoxication by Coriaria myrtifolia: a case study .. Anales espanoles de pediatria, 1997, vol. 46, no. 1, p. 81-2.
Cheng, M.A., de Freitas, F.J. Therapeutic possibilities of coriaria myrtifolia L. in high dilutions. International journal of high dilution research, 2011, vol. 10, no. 36, p. 211-214.
Perkin, A.G. XLII. - Yellow colouring principles contained in various tannin matters. Part VII. Arctostaphylos Uva ursi, H�matoxylon Campeachianum, Rhus Metopium Myrica Gale, Coriaria myrtifolia, and Robinia pseudacacia. Journal of the chemical society, transactions, 1900, vol. 77, p. 423-432. DOI
Maloney, A. H. The pharmacological action of coriamyrtin. J. pharmacol., 1936, vol. 57, p. 361-75.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature